Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

ViroPharma

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.

The moving parts of orphan drug development

The moving parts of orphan drug development bolted on Viropharma in a $4.2bn deal announced last November.

Shire spells out why AbbVie takeover is a bad idea

Shire spells out why AbbVie takeover is a bad idea of its $4.2bn acquisition of Viropharma in January.

Pharma deals during May 2014

Pharma deals during May 2014 Shire is really motoring. It acquired Viropharma last November for $4.2bn which contributed $93m of sales in the first quarter of this year.

Shire boosts rare disease portfolio with $260m Lumena deal

Shire boosts rare disease portfolio with $260m Lumena deal bolted on Viropharma in a $4.2bn deal announced last November.

Shire to file Vyvanse for binge-eating in Q3

Shire to file Vyvanse for binge-eating in Q3 The Viropharma deal - which closed last month - brings in an already-marketed drug for hereditary angioedema with sales running at around $100m a quarter last year. ... After a strong performance in 2013, and the completion of the ViroPharma acquisition,

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...